Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Development services for gene and cell therapies is planned to begin first in 2025
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Evinova will operate as a separate health-tech business within AstraZeneca
The company has raised US$4.5 million in funding for its AI operating system
European operations' revenue grew 58.4% to Rs 599.7 crore
Subscribe To Our Newsletter & Stay Updated
